Trump Rule to Put Prices in Drug Ads Is Shot Down by Judge
- Judge says administration overstepped regulatory authority
- Rule would have had drugmakers put prices in advertisements
This article is for subscribers only.
The Trump administration overstepped its authority with a rule to force drug companies to include the price of their medicine in advertisements, a federal judge ruled Monday.
Merck & Co., Eli Lilly & Co., Amgen Inc. and a trade group for advertisers sued the government last month to block the regulation, which would have required the companies to include drug list prices in the ads, which are a key part of pharmaceutical marketing.